| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |